Bullfrog AI Holdings, Inc. (BFRG)

NASDAQ: BFRG · IEX Real-Time Price · USD
4.590
+0.690 (17.69%)
At close: Feb 26, 2024, 4:00 PM
4.730
+0.140 (3.05%)
Pre-market: Feb 27, 2024, 8:02 AM EST
17.69%
Market Cap 31.55M
Revenue (ttm) 75,000
Net Income (ttm) -4.75M
Shares Out 7.12M
EPS (ttm) -0.86
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 12,329
Open 3.900
Previous Close 3.900
Day's Range 3.890 - 4.720
52-Week Range 2.360 - 9.500
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Mar 12, 2024

About BFRG

Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-a... [Read more]

Sector Healthcare
IPO Date Feb 14, 2023
Employees 11
Stock Exchange NASDAQ
Ticker Symbol BFRG
Full Company Profile

Financial Performance

Financial Statements

News

BullFrog AI Announces Underwriter's Decision to Exercise Over-Allotment Option to Purchase 218,382 Shares of the Company's Common Stock

GAITHERSBURG, Md., Feb. 21, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial in...

5 days ago - GlobeNewsWire

BullFrog AI to Discuss Findings from its Collaboration with Lieber Institute for Brain Development in Fireside Chat Hosted by RedChip

GAITHERSBURG, Md., Feb. 09, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial i...

18 days ago - GlobeNewsWire

WallachBeth Capital Announces Closing Of Bullfrog AI $5.7 Million Public Offering

JERSEY CITY, N.J. , Feb. 5, 2024 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today BullFrog AI Holdings, Inc. (NASDAQ...

21 days ago - PRNewsWire

BullFrog AI Announces Closing of $5.7 Million Public Offering

GAITHERSBURG, Md., Feb. 05, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial in...

21 days ago - GlobeNewsWire

WallachBeth Capital Announces Bullfrog AI Pricing of $5.7 Million Public Offering

JERSEY CITY, N.J. , Feb. 1, 2024 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that BullFrog AI Holdings, Inc. (N...

25 days ago - PRNewsWire

Bullfrog AI Announces Pricing of $5.7 Million Public Offering

GAITHERSBURG, Md., Feb. 01, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using artificial in...

25 days ago - GlobeNewsWire

BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala

GAITHERSBURG, Md., Jan. 26, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial i...

4 weeks ago - GlobeNewsWire

Bullfrog AI: advancing technologies in leaps and bounds

If Bullfrog AI NASDAQ: BFRG is not on your radar yet, it should be. This company is an emerging leader in a subset of AI that will have one of the furthest-reaching impacts on humanity: drug discovery...

5 weeks ago - MarketBeat

This AI stock is up 30% on Wednesday: find out more

Bullfrog AI Holdings Inc (NASDAQ: BFRG) says early results of its work with the Lieber Institute for Brain Development have been positive. Its shares are up 35% at writing.

5 weeks ago - Invezz

BullFrog AI's Collaboration with Lieber Institute for Brain Development Yields Potentially Groundbreaking Biological Stratification of Brain Expression Data

GAITHERSBURG, Md., Jan. 17, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial i...

5 weeks ago - GlobeNewsWire

BullFrog AI Announces Issuance of Australian Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer

GAITHERSBURG, Md., Jan. 16, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial i...

6 weeks ago - GlobeNewsWire

BullFrog AI to Present at Webull LIVE! Healthcare Webinar on January 17

GAITHERSBURG, Md., Jan. 11, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial i...

6 weeks ago - GlobeNewsWire

BullFrog AI Issues Letter to Shareholders

GAITHERSBURG, Md., Dec. 29, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial i...

2 months ago - GlobeNewsWire

BullFrog AI Launches Preclinical Study to Investigate BF-114's Potential in Battling Obesity

The market for obesity drugs is projected to exceed $77 billion by 2030 Dr. Randy Seeley, a recognized expert on novel treatments for obesity, to lead study GAITHERSBURG, Md., Dec. 06, 2023 (GLOBE NEW...

2 months ago - GlobeNewsWire

ASP Isotopes and Bullfrog AI Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

ORLANDO, FL / ACCESSWIRE / October 27, 2023 / RedChip Companies will air interviews with ASP Isotopes Inc. (NASDAQ:ASPI) and BullFrog AI Holdings, Inc. (NASDAQ:BFRG)(NASDAQ:BFRGW) on The RedChip Small...

Other symbols: ASPI
4 months ago - Accesswire

BullFrog AI to Present at Benzinga All Access Event on October 20

GAITHERSBURG, Md., Oct. 18, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial i...

4 months ago - GlobeNewsWire

BullFrog AI Announces Identification of Novel Potential Drug Targets for Colorectal Cancer Using Its AI-Driven bfLEAP™ Platform

Discoveries generated by analyzing The Cancer Genome Atlas using proprietary bfLEAP™ platform Target validation will be conducted through partnership with J. Craig Venter Institute (JCVI), a world-lea...

5 months ago - GlobeNewsWire

BullFrog AI Founder and CEO Vin Singh to Present Company Overview at BioFuture 2023

GAITHERSBURG, Md., Sept. 25, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial ...

5 months ago - GlobeNewsWire

BullFrog AI Announces Launch of BullFrog Data Networks™, a Data Insights Tool Powered by the bfLEAP™ Platform

Purpose-built Data Product Offers Customized Visualization of Relationships and Pathways for Specific Disease Indications Built from High-dimension, Multi-modal Data Sets Purpose-built Data Product Of...

5 months ago - GlobeNewsWire

BullFrog AI Founder and CEO Vin Singh to Present Company Overview at Maxim Group's Emerging Growth in AI Virtual Tech Conference Series

GAITHERSBURG, Md., Sept. 14, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial ...

5 months ago - GlobeNewsWire

BullFrog AI Announces Three-Year Global Strategic Partnership with the Lieber Institute for Brain Development

The Strategic Collaboration will Leverage BullFrog AI's bfLEAP™ AI Platform to Accelerate R&D Initiatives, Including New Drug Target and Disease Biomarker Identification The Strategic Collaboration wi...

5 months ago - GlobeNewsWire

BullFrog AI Announces Investor Webinar with CEO and Founder Vin Singh on Thursday, September 14, 2023

GAITHERSBURG, Md., Sept. 07, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial ...

6 months ago - GlobeNewsWire

BullFrog AI Technology Licensed from Johns Hopkins University APL Named Finalist in R&D 100 Awards

Proprietary Machine Learning Technology Powering bfLEAP™ Drug Discovery Platform Among Best in IT/Electrical Category Proprietary Machine Learning Technology Powering bfLEAP™ Drug Discovery Platform A...

6 months ago - GlobeNewsWire

RedChip Launches 'Small Stocks, Big Money' Podcast

New podcast series shines a spotlight on undervalued small-cap and microcap stocks ORLANDO, FL / ACCESSWIRE / August 2, 2023 / RedChip Companies, a renowned international investor relations firm speci...

Other symbols: LTRNRVPHSTSSZOM
7 months ago - Accesswire

BullFrog AI: Soaring On Breaking News And AI Potential

BullFrog AI NASDAQ: BFRG surged 44.22% higher yesterday on breaking news and traded almost 55 million shares. The digital pharmaceutical company encompassing artificial intelligence (AI) and machine l...

7 months ago - MarketBeat